Cowden syndrome laboratory findings: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{VKG}} | {{CMG}}; {{AE}} {{VKG}} | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of [ | [[Laboratory]] findings consistent with the [[diagnosis]] of [[cowden syndrome]] include [[skin biopsy]], chemistry panels, [[urinalysis]], [[thyroid function tests]] and cbc count. | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
Revision as of 18:20, 7 March 2019
|
Cowden syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cowden syndrome laboratory findings On the Web |
|
American Roentgen Ray Society Images of Cowden syndrome laboratory findings |
|
Risk calculators and risk factors for Cowden syndrome laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
Laboratory findings consistent with the diagnosis of cowden syndrome include skin biopsy, chemistry panels, urinalysis, thyroid function tests and cbc count.
Laboratory Findings
Laboratory findings consistent with the diagnosis of cowden syndrome include:
Gene testing
- PTEN mutation testing by following:
- Sequence analysis of coding region
- Deletion/duplication analysis
- Sequence analysis of promoter region